---
title: "Atherosclerosis in Chronic Kidney Disease: Early Prevention Matters"
id: "kidney-international-21-atherosclerosis-in-chronic-kidney-disease-early-prevention-is-better-than-late-treatment"
canonical_url: "https://medichelpline.com/clinical-feed/kidney-international-21-atherosclerosis-in-chronic-kidney-disease-early-prevention-is-better-than-late-treatment"
content_type: "clinical_feed_article"
specialty: "Nephrology"
source_name: "Kidney International"
source_url: "https://www.kidney-international.org/article/S0085-2538(25)00954-8/fulltext?rss=yes"
published_at: "2026-03-18T12:00:00.000Z"
evidence_level: "Journal Feed"
license: "CC-BY-NC-4.0 / Informational Use"
---
# Atherosclerosis in Chronic Kidney Disease: Early Prevention Matters
## Provenance & Clinical Metadata
- **Canonical URL:** https://medichelpline.com/clinical-feed/kidney-international-21-atherosclerosis-in-chronic-kidney-disease-early-prevention-is-better-than-late-treatment
- **Specialty:** [Nephrology](https://medichelpline.com/clinical-feed/nephrology.md)
- **Primary Source:** Kidney International
- **Source URL:** [Original Journal Publication](https://www.kidney-international.org/article/S0085-2538(25)00954-8/fulltext?rss=yes)
- **Published At:** 2026-03-18T12:00:00.000Z
- **Evidence Rating:** Journal Feed
## Executive GIST (TL;DR)
CKD substantially heightens cardiovascular mortality risk, potentially exceeding deaths from progression to kidney failure. In 2021, CKD directly caused 1.53 million deaths globally and contributed to 2.1 million cardiovascular deaths indirectly, per the 2024 Global Burden of Disease Report. The association between CKD and elevated cardiovascular risk is linked to a higher prevalence of atherosclerosis risk factors commonly observed in CKD patients, including hypertension, diabetes, obesity, and dyslipidemia. The source notes the potential impact of CKD on cardiovascular outcomes but does not provide data on specific prevention or treatment strategies. Uncertainty remains regarding how early preventive measures directly translate to reduced cardiovascular mortality in CKD, given the information available. Further details on intervention effects or quantitative risk reduction are not included in the provided material.
## Clinical Analysis & Structured Key Points
Kidney International published a clinical update in Research Highlights on 18 Mar 2026. The item focuses on Atherosclerosis in chronic kidney disease—early prevention is better than late treatment. Review the original article for the full source wording and details.
## Related Clinical Research

- [Use Of Kidney-Preserving Medications In Breastfeeding](https://medichelpline.com/clinical-feed/kidney-international-63-use-of-kidney-preserving-medications-in-breastfeeding.md)
- [Molecular Links Between Coronary Artery Disease and Cancer: Inflammation, Immunometabolism, Thromb](https://medichelpline.com/clinical-feed/frontiers-in-immunology-14-molecular-basis-of-coronary-artery-disease-malignancy-comorbidity-inflammation.md)
- [Hyperuricemia and Gout in People Living with HIV: Systematic Review and Meta-analysis Protocol](https://medichelpline.com/clinical-feed/plos-one-6-urate-dysregulation-hyperuricemia-and-gout-among-people-living-with-hiv-a.md)
- [Single-cell scTWAS identifies immune cell–specific genes linked to gestational diabetes](https://medichelpline.com/clinical-feed/plos-one-0-leveraging-expression-quantitative-trait-loci-information-in-single-cell.md)
- [Obesity-related multimorbidity patterns and reduced quality of life in Iranian adults](https://medichelpline.com/clinical-feed/bmj-open-19-obesity-related-patterns-of-multimorbidity-and-their-association-with-health.md)

## Navigation
- [← Back to Nephrology Feed](https://medichelpline.com/clinical-feed/nephrology.md)
- [← All Clinical Specialties](https://medichelpline.com/clinical-feed.md)
## Medical & Regulatory Disclaimer

> [!CAUTION]
> MedicHelpline content is structured for research, educational, and professional discovery purposes. It does not constitute individual medical advice, clinical diagnosis, or treatment recommendations.
> Always verify dosing, contraindications, and regulatory alerts against official product labeling and primary regulatory sources before clinical decision-making.